Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
HE.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.33SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FY.4.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.5.99SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
HW.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.4.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FE.1.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
HA.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
GM.3.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FT.3.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
JD.1.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
GJ.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
HT.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FL.20SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
JH.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
CK.1.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
XBB.1.34.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
EG.2.5SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
JK.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.5.106SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.5.11SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FE.1.1.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FY.4.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
GZ.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
FT.3.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
EG.4.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
JZ.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
HS.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XBB.1.5.73SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
HV.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
JN.1.8SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.4.5SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.8.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.45SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.4.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
XDRSYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.38SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.43.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.28SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.18SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.29SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1.7.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
KV.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
XBB.1.16.15SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
JN.1.39SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JN.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
JD.1.1.6SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
HK.3.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used